Xconomy

@Xconomy

Authoritative voice on biotech's exponential economy: news, events, awards, webinars, whitepapers, , , ,

United States
Vrijeme pridruživanja: travanj 2009.

Tweetovi

Blokirali ste korisnika/cu @Xconomy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Xconomy

  1. Prikvačeni tweet
    23. sij
    Poništi
  2. prije 6 sati
    Poništi
  3. prije 13 sati
    Poništi
  4. prije 13 sati
    Poništi
  5. proslijedio/la je Tweet
    prije 18 sati
    Poništi
  6. 4. velj

    [FEB. 6 PARTNER EVENT] NYCHBL presents 7th annual Healthcare Investment Trends. New this year: Big Exits in 2019, w/ NYC founders who had big exits. Use code HCVC-PARTNER for $25 discount. REGISTER: Sponsored by

    Poništi
  7. 4. velj
    Poništi
  8. proslijedio/la je Tweet
    4. velj

    Did you miss last month? Would you like to catch up with all the latest news & views? Click to read all the analysis from our experts who attended the event:

    Poništi
  9. proslijedio/la je Tweet
    4. velj

    The alliance that began last year with accelerator now has its first : Anteros Pharmaceuticals is developing a small molecule drug to treat ...

    Poništi
  10. proslijedio/la je Tweet
    4. velj

    of and asks experts whether off-the-shelf is the way to go for therapy manufacture. Check out his work on allogeneic possibilities here:

    Poništi
  11. 4. velj

    Our latest video on the importance of small and emerging biotech companies on the leading edge of innovation in drug development is now live. Featuring :

    Poništi
  12. 4. velj
    Poništi
  13. 4. velj
    Poništi
  14. 3. velj
    Poništi
  15. 3. velj

    [FEB. 6 PARTNER EVENT] Where will the dollars flow in 2020? Hear from investment experts and co-founders with big exits in 2019. Use HCVC-PARTNER for $25 off registration. REGISTER: Presented by NYCHBL & BDO Health

    Poništi
  16. 3. velj
    Poništi
  17. 3. velj
    Poništi
  18. 3. velj
    Poništi
  19. 3. velj
    Poništi
  20. 3. velj
    Poništi
  21. proslijedio/la je Tweet
    3. velj

    ICYMI, won FDA approval Friday for , a peanut allergy therapy. The FDA decision covers kids 4-17 yrs.old...

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·